It is known that women have higher levels of high density lipoprotein (HDL) cholesterol than men. The authors examined the association between HDL cholesterol and biologic sex in 8,631 women and 10,690 men aged 45-54 years from six countries studied between 1972 and 1989. The variation in the sex difference for HDL cholesterol was significant; the smallest difference (0.06 mmol/liter) was seen in China and the largest (0.40 mmol/liter) in Canada. Adjustment for differences in body mass index, smoking, alcohol use, and heart rate reduced but did not eliminate the variability. The sex difference in HDL cholesterol levels, usually assumed to be due to biologic factors, differs across cultures and may be related to environmental factors. Am J Epidemiol 1996;143:1100-6. alcohol drinking; body mass index; lipoproteins, HDL cholesterol; sex factors; smoking Elevated levels of high density lipoprotein (HDL) cholesterol have been shown to be associated with a reduced risk of coronary heart disease in many epidemiologic studies (1-4). It has also been observed in many studies that women have higher HDL cholesterol levels than do men, and this has been hypothesized to be one of the reasons women have a lower incidence of coronary disease (1, 5-9). It is thus of interest to estimate the mean difference in HDL cholesterol between men and women and to determine whether this difference is similar in different ethnic and cultural settings. It is also important to determine whether differences in factors such as obesity, alcohol consumption, and cigarette smoking, which are known to be correlated with HDL cholesterol levels, can explain the sex difference in HDL cholesterol. We report here the estimated sex differences in HDL cholesterol levels in 23 samples from population-based epidemiologic studies conducted in six different countries. Our specific purposes were: 1) to estimate the sex difference in HDL cholesterol; 2) to determine whether this difference was similar in magnitude across a variety of ethnic and cultural populations; 3) to estimate the association of a set of correlates with HDL cholesterol in different cultures; and 4) to adjust the estimated sex difference for differences in these correlates.
Elevated levels of high density lipoprotein (HDL) cholesterol have been shown to be associated with a reduced risk of coronary heart disease in many epidemiologic studies (1) (2) (3) (4) . It has also been observed in many studies that women have higher HDL cholesterol levels than do men, and this has been hypothesized to be one of the reasons women have a lower incidence of coronary disease (1, (5) (6) (7) (8) (9) . It is thus of interest to estimate the mean difference in HDL cholesterol between men and women and to determine whether this difference is similar in different ethnic and cultural settings. It is also important to determine whether differences in factors such as obesity, alcohol consumption, and cigarette smoking, which are known to be correlated with HDL cholesterol levels, can explain the sex difference in HDL cholesterol.
We report here the estimated sex differences in HDL cholesterol levels in 23 samples from population-based epidemiologic studies conducted in six different countries. Our specific purposes were: 1) to estimate the sex difference in HDL cholesterol; 2) to determine whether this difference was similar in magnitude across a variety of ethnic and cultural populations; 3) to estimate the association of a set of correlates with HDL cholesterol in different cultures; and 4) to adjust the estimated sex difference for differences in these correlates.
MATERIALS AND METHODS
This report includes data from population-based studies conducted in Canada (one population), China (four populations), Israel (one population), Poland (two populations), Russia (two populations), and the United States (13 populations). Data collection for the US Lipid Research Clinics (LRC), the Atherosclerosis Risk in Communities (ARIC) Study, and the Canadian and Israeli LRC studies was sponsored by the US National Heart, Lung, and Blood Institute. Data collection in the People's Republic of China, the Russian Federation (formerly the Soviet Union), and Poland was sponsored by grants from the respective governments and by bilateral agreements between the respective governments and the US government. The Department of Biostatistics of the University of North Carolina, under contracts from the National Heart, Lung, and Blood Institute, served as the coordinating center for all of the studies.
This analysis was restricted to men and women aged 45-54 years. Other exclusions included participants known not to have fasted for at least 12 hours, pregnant women, and persons with missing data for HDL cholesterol. Table 1 describes the populations studied by country, and gives the dates of the studies and the sample sizes that were used in this analysis. Study designs, populations studied, methods used, and standardization procedures have been described in detail elsewhere (10) (11) (12) (13) (14) (15) (16) (17) (18) . Brief descriptions are given here.
ARIC data were collected in 1987-1989 from probability samples of four US communities. Data were collected in various ethnic groups, of which only white and black men and women were selected for this analysis. The Polish data were obtained from random samples of an urban population and a rural population screened in 1983-1984. In China, samples were selected from two regions and in two settings within each region. The two regions were Beijing in the north of China and Guangzhou in the south. In each region, samples of urban workers and rural farmers were obtained. Each LRC study screened participants selected from separate, well-defined populations in the United States, Canada, Israel, and Russia. All 13 clinics (nine US, one Canadian, one Israeli, and two Russian) followed a standardized protocol. The North American and Israeli clinics were screened twice between 1972 and 1975. A randomly chosen 15 percent of all participants from the first screening were invited to the second screening, along with a selected group of Data on age, smoking, alcohol consumption, and hormone use by women were obtained using a standard questionnaire. Weight was measured on a balanced scale while the participant stood without shoes and heavy outer garments. Height was measured in the standing position. Body mass index was computed as weight (kg) divided by height (m) squared. In all studies but the ARIC Study, heart rate was measured over a 15-second interval on the right radial artery and then multiplied by 4 for a 1-minute estimate. In the ARIC Study, 1-minute heart rate was measured while the participant lay in a supine position during a standard 12-lead electrocardiographic examination.
Lipid laboratories in each country were standardized according to the Centers for Disease Control program. Plasma lipid determinations were made in all of the samples except those from China and ARIC, where serum was used. Serum samples were adjusted to be equivalent to plasma samples using a standard formula (19) . In Poland, the US LRC studies, Canada, Russia, and Israel, HDL cholesterol was evaluated in the supernatant after precipitation of other cholesterol fractions with heparin and manganese (Mn2 + ) (20) . In the ARIC Study and China, HDL cholesterol was measured using a mixture of dextran sulfate, an analog of heparin, and magnesium (Mg2 + ) (21) .
Since different laboratories were used in the studies, comparison of HDL cholesterol levels between males and females was done within each sampled population and the estimates were combined across samples. For descriptive purposes, age-adjusted differences between men and women were computed using direct standardization and the World Health Organization standard. Totals for countries with more than one sample were obtained by weighting the average inversely proportional to the variance of the withinsample variance of the sex difference. Mixed linear models were used to estimate the association between sex and HDL cholesterol within and across sampled populations. In these models, the sampled population (23 levels) was considered a random effect and all other variables (e.g., age, sex, body mass index) were considered fixed effects. PROC MIXED in SAS (22) was used to compute data in the mixed models.
Since HDL cholesterol levels differed by ethnicity within the US samples, the ARIC data were divided into five groups, three white (Forsyth County, North Carolina; Minnesota; and Washington County, Maryland) and two black (Forsyth County and Jackson, Mississippi). Results are presented separately for ARIC blacks and whites. Table 2 gives age-adjusted mean HDL cholesterol levels by sex, as well as the 95 percent confidence interval for the sex difference, in each sampled population. The mixed linear model analysis indicated that the variation among countries was far greater than the variation within countries; therefore, we will concentrate here on differences among countries.
RESULTS
By comparison with women in the other countries, the Chinese and Israeli women had lower mean HDL cholesterol levels. Mean HDL cholesterol levels were similar among women in the other sampled populations. There was more variation in mean HDL cholesterol among men, with the US white, Canadian, and Israeli men having lower mean levels than men from the other countries.
The sex differences are plotted in figure 1 and vary markedly by country, from a low of 0.06 mmol/liter in China to approximately 0.40 mmol/liter in the North American white populations (Canada, ARIC whites, and the US LRC studies). The linear model analysis indicated that the differences among the countries were statistically significant (p < 0.0001).
A linear model was used to estimate the associations of smoking, alcohol consumption, body mass index, heart rate, and hormone use (females only) with HDL cholesterol. Alcohol consumption data were not available for the Israeli sample, so it was not included in this model. The interaction tests in the model indicated that the strength of the associations between smoking, alcohol, and heart rate and HDL cholesterol differed in women and men, while the association between body mass index and HDL cholesterol was similar in men and women. Table 3 gives the estimated differences in HDL cholesterol associated with fixed differences in these variables, as estimated from these crosssectional data. It is noteworthy that cigarette smoking and alcohol consumption were estimated to have much stronger effects on HDL cholesterol in women than in men. The association of HDL cholesterol with use of exogenous hormones was sizable. In our samples, few women from Poland, Russia, or China were taking hormones at the time of the examination; thus, this effect was largely confined to the North American samples. Figure 2 shows the sex differences in HDL cholesterol after adjustment for age, smoking, alcohol con- sumption, heart rate, body mass index, and hormone use. In these models, the sex X correlate interaction terms were used so that adjustment took account of the differences in association noted above. Although variation in the HDL cholesterol sex difference among the countries was reduced by this adjustment (range: 0.37 mmol/liter in Canada to 0.15 mmol/liter in China), the difference among countries remained statistically significant (p < 0.0001).
To estimate the sex-specific covariate-adjusted mean value for each country, we conducted separate linear analyses for each sex which included the covariates listed above. The covariate adjustment had very little effect on the variation among countries in males. The range among the males from cultures. Moreover, the magnitude of this difference is greatly influenced by environmental factors such as cigarette smoking, alcohol consumption, body mass, and exogenous hormone use. The association of alcohol consumption and smoking with HDL cholesterol level was found to be stronger in women than in men. Although differences in these factors explained some of the variation among populations, considerable variation in the estimated sex difference remained after adjustment.
These results indicate that alcohol consumption, cigarette smoking, obesity, heart rate, and exogenous hormone use clearly influence the magnitude of the difference in HDL cholesterol between men and women. Thus, not all of the observed sex difference in HDL cholesterol can be attributed to intrinsic physiologic or endogenous hormonal differences.
There are at least four possible explanations for the fact that the correlates of HDL cholesterol only partially explained the differences among the countries. First, genetic differences among the populations may affect the magnitude of the sex difference. Second, there may be other environmental correlates of HDL cholesterol not measured in these studies which would explain the differences. Third, variability in the measurement of the correlates could lead to underadjustment of the associations. If a covariate has reliability R (:£l), adjustment removes 1007? percent of the initial confounding effect (23) . For example, the reliability of heart rate has been found to be 0.60 in INTERSALT (24) . Thus, the covariate adjustment is approximately 60 percent complete. Since all of the covariates were subject to variability, adjustment was likely not to have completely adjusted for possible confounding. Fourth, although laboratory variation is a possible explanation, it is not likely to explain the sex difference, since our comparisons were done within-center. Laboratory variation could be a possible explanation for the differences in absolute levels of HDL cholesterol seen across populations. We suspect that all four of these possible explanations operated to cause the differences among countries, but we have no empirical method for estimating the magnitude of their relative effects.
It has been hypothesized that the sex difference in HDL cholesterol may partially explain the excess coronary heart disease morbidity and mortality seen in males. It will be interesting to compare the differences in morbidity and mortality among the countries and populations sampled and to correlate sex differences in disease incidence with sex differences in factors such as HDL cholesterol. Preliminary data from Chinese national health statistics have shown that the male: female ratio of age-standardized coronary disease mortality rates is distinctly lower (1.4: 1) in Beijing and Guangzhou than in the United States and other countries with higher overall coronary disease mortality (25) . Morbidity and mortality data are currently being collected in several of these populations.
